Codes / ICD10CM / T49.0

T49.0 Poisoning by, adverse effect of and underdosing of local antifungal, anti-infective and anti-inflammatory drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by, adverse effect of and underdosing of local antifungal, anti-infective and anti-inflammatory drugs (ICD Code: T49.0)

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to topical medications used for antifungal, anti-infective, or anti-inflammatory purposes. It includes unintended harm from these drugs, whether due to excessive exposure, unintended reactions, or insufficient dosing.

Causes

Poisoning or adverse effects may result from incorrect application, accidental ingestion, or overuse of topical medications. Underdosing can occur from inadequate application, missed doses, or subtherapeutic concentrations. Adverse effects may stem from allergic reactions, drug interactions, or sensitivity to ingredients.

Risk Factors

  • Individuals with compromised skin barriers (e.g., eczema, wounds) are at higher risk for systemic absorption. Elderly patients or those with cognitive impairments may misuse medications. Concurrent use of other topical or systemic drugs can increase interaction risks.

Symptoms

  • Symptoms vary by drug and exposure: local reactions (rash, itching, burning) for adverse effects; systemic signs (nausea, dizziness) if absorbed; or persistent infection/inflammation from underdosing. Severe cases may involve organ toxicity or anaphylaxis.

Diagnosis

Diagnosis involves reviewing medication history, clinical presentation, and exposure details. Physical exams assess skin or systemic involvement. Lab tests (e.g., drug levels, allergy panels) may confirm toxicity or underdosing, especially in severe cases.

Treatment Options

  • For poisoning, remove the drug and provide supportive care (e.g., hydration, monitoring). Adverse effects may require discontinuation and symptomatic treatment (e.g., antihistamines). Underdosing is managed by adjusting dosing or application frequency per guidelines.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Most mild cases resolve with discontinuation. Severe poisoning may require hospitalization. Follow-up ensures resolution of symptoms and addresses underlying causes (e.g., dosing errors).

Complications

  • Complications include skin damage, systemic organ injury (e.g., liver/kidney), or treatment failure from underdosing. Chronic exposure may lead to resistance or recurrent infections.

Lifestyle & Prevention

  • Use medications as directed, avoid overapplication, and store products safely. Educate patients on proper use, especially for high-risk groups (e.g., elderly, children). Patch testing can identify allergies before full use.

When to Seek Professional Help

  • Seek care for severe reactions (e.g., swelling, difficulty breathing), suspected poisoning, or worsening symptoms despite treatment. Immediate attention is needed for systemic signs (e.g., dizziness, confusion).

Tips for Medical Coders

  • Document the specific drug, route (topical), and event (poisoning, adverse effect, underdosing) clearly. Specify if the event was accidental, intentional, or therapeutic. Include details on clinical findings and treatment to support code assignment.
Book a walkthrough

T49.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.